Article Information
History
- April 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Erin C. Williams1,3,
- Alexander Kizhner2,
- Valerie S. Stark1,4,
- Aria Nawab1,
- Daniel D. Muniz1,
- Felipe Echeverri Tribin3,
- Juan Manuel Carreño6,
- Dominika Bielak6,
- Gagandeep Singh6,
- Michael E. Hoffer1,5,
- Florian Krammer6,7,
- Suresh Pallikkuth2 and
- Savita Pahwa2,*
- 1Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, 33136 USA
- 2Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, 33146, USA
- 3Department of Biomedical Engineering, University of Miami, Miami, Florida, 33136, USA
- 4University of Miami Miller School of Medicine, Miami, Florida, 33136, USA
- 5Department of Neurological Surgery, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- 6Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
- 7Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
- ↵*Corresponding author:
Savita Pahwa, M.D. at the Department of Microbiology and Immunology (Pediatrics and Medicine), University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL 33136, USA., E-mail: spahwa{at}med.miami.edu, Phone: 305-243-7732, Fax: 305-243-7211
Posted April 06, 2022.
Predictors for Reactogenicity and Humoral Immunity to SARS-CoV-2 Following Infection and mRNA Vaccination: A Regularized Mixed-Effects Modelling Approach
